Area of research
Endocrinology, Diabetes and Metabolism · Immunology and Allergy
Research interest
Research interests include Diabetes Management and Research, Diabetes Treatment and Management, Diabetes Management and Education, and Food Allergy and Anaphylaxis Research.
The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms.
Is there an HbA1c Threshold for Symptoms of Chronic Hyperglycemia?
Salvation Expectations of Patients of Medicine, Complementary and Alternative Medicine and Religion.
Progression of Diabetic Complications in Subgroups of People with Long Term Diabetes Type 1 According to Clinical Course.
Correction to: Salvation Expectations of Patients of Medicine, Complementary and Alternative Medicine and Religion.
Association between Flash Glucose Monitoring and Metabolic Control as well as Treatment Satisfaction in Outpatients With Diabetes Type 1.
Reduction of Severe Hypoglycaemia in People with Type 2 Diabetes after a Structured Inpatient Intervention.
Blood Sugar Targets in Surgical Intensive Care—Management and Special Considerations in Patients With Diabetes
Diabetes related distress is high in inpatients with diabetes.
Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of Patients with Diabetes Mellitus Type 2.
Long-term outcome of persons with diabetic and non-diabetic neuro-osteoarthropathy after foot correction using external fixation.
Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care.
Association Between Glycaemic Control and the Intake of Thiazide Diuretics, Beta Blockers and Levothyroxine in People Without Diabetes.
Adequate Structured Inpatient Diabetes Intervention in People With Type 1 Diabetes Improves Metabolic Control and Frequency of Hypoglycaemia.
Changes in incidence of severe hypoglycaemia in people with type 2 diabetes from 2006 to 2016: analysis based on health insurance data in Germany considering the anti-hyperglycaemic medication.
Successful Treatment with Bedtime Basal Insulin Added to Metformin without Weight Gain or Hypoglycaemia over Three Years.
Definition, Classification and Diagnosis of Diabetes Mellitus.
Preventing misdiagnosis of diabetes in the elderly: age-dependent HbA1c reference intervals derived from two population-based study cohorts.
Expectations and fear of diabetes-related long-term complications in people with type 2 diabetes at primary care level.
Overestimation of Risk and Increased Fear of Long-term Complications of Diabetes in People with Type 1 and 2 Diabetes.
Snacking is Common in People with Diabetes Type 1 and Type 2 with Insulin Therapy and Is Not Associated With Metabolic Control or Quality of Life.
Diabetes-related distress is reduced in people with type 1, but not type 2 diabetes after participating in a diabetes treatment and teaching programme.
Agonistic autoantibodies against B2-adrenergic receptors correlating with macrovascular disease in longstanding diabetes type 2.
Correction to: Agonistic autoantibodies against adrenergic receptors correlating with antihypertensive therapy in long-standing diabetes type 2.
Identification of a blood based metabolomic classifer for the detection of ovarian cancer – MeDOC
Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement
Recommendations for the transition of patients with ADHD from child to adult healthcare services: a consensus statement from the UK adult ADHD network
Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models
Global Allergy Forum and Second Davos Declaration 2013 Allergy: Barriers to cure - challenges and actions to be taken
The age of attaining highest body weight correlates with lifespan in a genetically obese mouse model